JB Chemicals scales 52-week high on 35% surge in Q1 net profit
Double-digit growth in the domestic and international formulations segments helped JB Chemicals clock in robust numbers for the April-June quarter.10-08-2023
10-08-2023
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation09-08-2023
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Grant Of Options Under Employee Stock Option Scheme
Grant of options under Employee stock option scheme09-08-2023
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Setting-Up Of Proposed Step-Down Subsidiary
Setting-up of proposed step-down subsidiary09-08-2023
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Board Meeting Outcome for Unaudited Financial Results For The Quarter Ended On June 30, 2023
Unaudited Financial Results for the quarter ended on June 30, 202309-08-2023
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Intimation Of Schedule Of Analysts/Institutional Investors Meet
Intimation of schedule of Analysts/Institutional investors meet08-08-2023
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Allotment of Equity shares on exercise of stock options pursuant to Employee Stock Option Scheme07-08-2023
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Investors/analysts call with management01-08-2023
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Board Meeting Intimation for Unaudited Financial Results For The Quarter Ended On June 30, 2023.
J.B.CHEMICALS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/08/2023 ,inter alia, to consider and approve unaudited financial results for the quarter ended on June 30, 2023.01-08-2023